Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.

Research output: Contribution to journalArticle

Bibtex

@article{fb3356fd873349f98165738293d5b3b2,
title = "Circulating complexes between tumour necrosis factor-alpha and etanercept predict long-term efficacy of etanercept in juvenile idiopathic arthritis.",
abstract = "The relationship between tumour necrosis factor-alpha (TNF-α) and drug survival had not been studied in juvenile idiopathic arthritis (JIA) and there were no laboratory tests to predict the long-term efficacy of biological drugs for JIA. We studied if serum levels of TNF-α, free or bound to etanercept, could predict long-term efficacy of etanercept in children with JIA.",
author = "Robin Kahn and Elisabet Berthold and Birgitta Gullstrand and Tobias Schmidt and Fredrik Kahn and Pierre Geborek and Tore Saxne and Anders Bengtsson and Bengt M{\aa}nsson",
year = "2016",
doi = "10.1111/apa.13319",
language = "English",
volume = "105",
pages = "427--432",
journal = "Acta P{\ae}diatrica",
issn = "1651-2227",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}